Slattery W - Search Results

1

Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2.

Hung G, Li X, Faudoa R, Xeu Z, Kluwe L, Rhim JS, Slattery W, Lim D. Hung G, et al. Among authors: slattery w. Int J Oncol. 2002 Mar;20(3):475-82. Int J Oncol. 2002. PMID: 11836557

2

Establishment of primary vestibular schwannoma cultures from neurofibromatosis type-2 patients.

Hung G, Faudoa R, Li X, Xeu Z, Brackmann DE, Hitselberg W, Saleh E, Lee F, Gutmann DH, Slattery W 3rd, Rhim JS, Lim D. Hung G, et al. Among authors: slattery w 3rd. Int J Oncol. 1999 Mar;14(3):409-15. doi: 10.3892/ijo.14.3.409. Int J Oncol. 1999. PMID: 10024671

3

Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.

Hung G, Faudoa R, Baser ME, Xue Z, Kluwe L, Slattery W, Brackman D, Lim D. Hung G, et al. Among authors: slattery w. Cancer Genet Cytogenet. 2000 Apr 15;118(2):167-8. doi: 10.1016/s0165-4608(99)00201-0. Cancer Genet Cytogenet. 2000. PMID: 10748301

4

Immunohistochemistry study of human vestibular nerve schwannoma differentiation.

Hung G, Colton J, Fisher L, Oppenheimer M, Faudoa R, Slattery W, Linthicum F. Hung G, et al. Among authors: slattery w. Glia. 2002 Jun;38(4):363-70. doi: 10.1002/glia.10077. Glia. 2002. PMID: 12007148

5

Neurofibromatosis type 2.

Slattery WH. Slattery WH. Otolaryngol Clin North Am. 2015 Jun;48(3):443-60. doi: 10.1016/j.otc.2015.02.005. Otolaryngol Clin North Am. 2015. PMID: 26043141 Review.

6

Neurofibromatosis 2.

Hoa M, Slattery WH 3rd. Hoa M, et al. Otolaryngol Clin North Am. 2012 Apr;45(2):315-32, viii. doi: 10.1016/j.otc.2011.12.005. Otolaryngol Clin North Am. 2012. PMID: 22483819 Review.

7

Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.

Fisher LM, Doherty JK, Lev MH, Slattery WH. Fisher LM, et al. Otol Neurotol. 2009 Sep;30(6):835-41. doi: 10.1097/MAO.0b013e3181b2364c. Otol Neurotol. 2009. PMID: 19704365

8

Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects.

Slattery WH 3rd, Fisher LM, Iqbal Z, Oppenhiemer M. Slattery WH 3rd, et al. Otol Neurotol. 2004 Sep;25(5):811-7. doi: 10.1097/00129492-200409000-00027. Otol Neurotol. 2004. PMID: 15354016

9

Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients.

Plotkin SR, Merker VL, Muzikansky A, Barker FG 2nd, Slattery W 3rd. Plotkin SR, et al. Among authors: slattery w 3rd. Otol Neurotol. 2014 Jan;35(1):e50-6. doi: 10.1097/MAO.0000000000000239. Otol Neurotol. 2014. PMID: 24335938

10

Hearing changes after diagnosis in neurofibromatosis type 2.

Masuda A, Fisher LM, Oppenheimer ML, Iqbal Z, Slattery WH; Natural History Consortium. Masuda A, et al. Otol Neurotol. 2004 Mar;25(2):150-4. doi: 10.1097/00129492-200403000-00012. Otol Neurotol. 2004. PMID: 15021775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters